




Searching News Database: Raptor Pharmaceuticals
HSMN NewsFeed - 1 Jun 2021
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
HSMN NewsFeed - 24 Jan 2018
Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs
Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs
HSMN NewsFeed - 11 Jul 2017
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
HSMN NewsFeed - 22 Sep 2015
ImmunoCellular Therapeutics Appoints Mark A. Schlossberg and Gregg A. Lapointe to its Board of Directors
ImmunoCellular Therapeutics Appoints Mark A. Schlossberg and Gregg A. Lapointe to its Board of Directors
HSMN NewsFeed - 15 Oct 2013
La Jolla Pharmaceutical Company Announces Appointment of Two Additional Independent Directors
La Jolla Pharmaceutical Company Announces Appointment of Two Additional Independent Directors
HSMN NewsFeed - 15 May 2012
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 28 Jul 2009
Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
HSMN NewsFeed - 13 Apr 2009
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
HSMN NewsFeed - 8 Jul 2008
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
HSMN NewsFeed - 9 Jun 2008
Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntington's Disease
Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntington's Disease